Medial temporal lobe atrophy on MRI scans and the diagnosis of Alzheimer disease.
about
The clinical use of structural MRI in Alzheimer diseaseWhat can imaging tell us about cognitive impairment and dementia?Brain imaging in Alzheimer diseaseBiomarkers in dementia: clinical utility and new directionsStructural MR Imaging in the Diagnosis of Alzheimer's Disease and Other Neurodegenerative Dementia: Current Imaging Approach and Future PerspectivesNeuropsychiatric Symptom Clusters in Stroke and Transient Ischemic Attack by Cognitive Status and Stroke Subtype: Frequency and Relationships with Vascular Lesions, Brain Atrophy and AmyloidReliability and validity of an algorithm for the diagnosis of normal cognition, mild cognitive impairment, and dementia: implications for multicenter research studiesMR anatomy of deep brain nuclei with special reference to specific diseases and deep brain stimulation localization.Using visual rating to diagnose dementia: a critical evaluation of MRI atrophy scales.Initial experience in using continuous arterial spin-labeled MR imaging for early detection of Alzheimer diseaseDiagnosis and staging of mild cognitive impairment, using a modification of the clinical dementia rating scale: the mCDRPractical use of visual medial temporal lobe atrophy cut-off scores in Alzheimer's disease: Validation in a large memory clinic populationBoosting power for clinical trials using classifiers based on multiple biomarkers.T(1ρ) MRI in Alzheimer's disease: detection of pathological changes in medial temporal lobe.Correlation between volume and morphological changes in the hippocampal formation in Alzheimer's disease: rounding of the outline of the hippocampal body on coronal MR images.Role of structural MRI in Alzheimer's diseaseAn MRI-based semiquantitative index for the evaluation of brain atrophy and lesions in Alzheimer's disease, mild cognitive impairment and normal aging.The diagnosis and evaluation of dementia and mild cognitive impairment with emphasis on SPECT perfusion neuroimaging.Biomarkers of Alzheimer's disease: from central nervous system to periphery?Reducing case ascertainment costs in U.S. population studies of Alzheimer's disease, dementia, and cognitive impairment-Part 1Microstructural white matter changes, not hippocampal atrophy, detect early amnestic mild cognitive impairment.Minimal atrophy of the entorhinal cortex and hippocampus: progression of cognitive impairment.Proteome-based plasma markers of brain amyloid-β deposition in non-demented older individuals.The appropriate use of neuroimaging in the diagnostic work-up of dementia: an evidence-based analysisVolumetric and visual rating of magnetic resonance imaging scans in the diagnosis of amnestic mild cognitive impairment and Alzheimer's disease.Global gray matter changes in posterior cortical atrophy: a serial imaging study.T1rho MRI and CSF biomarkers in diagnosis of Alzheimer's disease.Evolution of the diagnostic criteria for degenerative and cognitive disorders.Should mild cognitive impairment be subtyped?Cross-validation of brain structural biomarkers and cognitive aging in a community-based studyRelationship of contextual cueing and hippocampal volume in amnestic mild cognitive impairment patients and cognitively normal older adultsLanguage background in early life may be related to neuropsychiatry symptoms in patients with Alzheimer diseaseHippocampal atrophy but not white-matter changes predicts the long-term cognitive response to cholinesterase inhibitors in Alzheimer's disease.Suspected early dementia.Combining structural brain changes improves the prediction of Alzheimer's disease and mild cognitive impairment.Posterior cerebral atrophy in the absence of medial temporal lobe atrophy in pathologically-confirmed Alzheimer's disease.The utility of age-specific cut-offs for visual rating of medial temporal atrophy in classifying Alzheimer's disease, MCI and cognitively normal elderly subjects.Identify the Atrophy of Alzheimer's Disease, Mild Cognitive Impairment and Normal Aging Using Morphometric MRI Analysis.Full diffusion characterization implicates regionally disparate neuropathology in mild cognitive impairment.Quantitative evaluation of Alzheimer's disease.
P2860
Q24609648-8A3418AE-DE82-454B-832A-24F720AD8918Q26749292-7D98B4DE-565B-4C01-9E3D-5D4391EF9703Q26996299-80EB31C0-D3ED-4775-AAA1-06026967A1E1Q27007086-A5EC543A-543C-4BFD-BDCB-436437D03CF6Q28077809-F3689292-746B-4A37-9084-F83CD525A672Q28554089-5E9CAEA4-CFCD-4C2D-8A71-EB4AC89BC9DFQ30387132-8F0DECA4-4844-4333-A0BB-3EB9B31E3113Q30765195-781C1652-EF38-4B07-982E-8117F59483BAQ30931423-4673D852-D0D9-435A-AF3A-35E9A3E72244Q33523947-9DFE9B8F-CD63-4F3B-891C-B97FB950B042Q33658302-C8A5B7E5-7B12-4FF2-B896-02696D155259Q33854681-09791AE6-D82C-4EAC-B32A-BA9B15923235Q33990250-C6DE494B-A1E3-4171-B1B9-2A55D9D60886Q34057880-753770DA-A4DD-4509-A7A2-E4D9D97D625BQ34164448-CE96BB07-AB56-497A-8AD2-3A59270D9B03Q34173192-23AC4E1A-E2E2-48EA-9C15-3F735A968C33Q34263702-788E9CD9-E959-4E14-995F-6D7A6AB69994Q34296479-5F605378-5090-4BC9-BD1F-2B13FD61AB09Q34442605-759A08CD-88C1-4BA9-82C6-F91DC6267463Q34604092-C8CE4F87-E47A-4964-AFF6-868BF95BC7D1Q34630119-6F5AD278-F693-41EF-B5E6-DE45FE342B4FQ34891983-F04DF306-2B50-4E40-84F7-6388AEA004ADQ35076119-09D25F91-4B36-40D2-8CE4-8D99796019D9Q35109977-7DC97EEC-70A9-497D-AD18-D6A88BE02E77Q35134849-81595F80-56F8-4A10-9040-4AA5B6053214Q35176229-10917F95-E314-409F-AD95-0B0DFDD37C91Q35221966-7F98B9C6-9BAE-434E-B9DE-74CF256FC755Q35708394-07392B51-205B-4E4A-B13C-874D44FD6357Q36002365-F2FAFC33-ABA6-4EA6-B891-DACED6E221A1Q36081649-26F52C03-B5F7-4DCD-991C-10DE83E85651Q36132524-86FCFC40-45F3-4215-B3A2-36F77A17D80CQ36275989-D9987F00-DEC2-43FF-9C80-E5BF4DF2097AQ36305905-136F4BF3-655A-4C4B-BFAC-835BD54147B3Q36363685-82D56364-339C-4618-82B9-67B50B5ABB42Q36374662-CA49586B-9621-46D4-89E2-2B8076BC3A39Q36852812-C94BD267-78F5-4466-A0F3-DEE994E4375DQ37181179-B56FFE1F-48A0-4A55-AB3A-6F6EDD07FBB0Q37345096-F6E0CFD3-7A0D-49CE-BB0D-A9D16FE2A204Q37432554-3F55769F-15C6-434C-9B7E-2D0AB66AE76AQ37596431-7F5AD3E0-41DE-4966-B575-FE133F2CF6B9
P2860
Medial temporal lobe atrophy on MRI scans and the diagnosis of Alzheimer disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Medial temporal lobe atrophy on MRI scans and the diagnosis of Alzheimer disease.
@en
Medial temporal lobe atrophy on MRI scans and the diagnosis of Alzheimer disease.
@nl
type
label
Medial temporal lobe atrophy on MRI scans and the diagnosis of Alzheimer disease.
@en
Medial temporal lobe atrophy on MRI scans and the diagnosis of Alzheimer disease.
@nl
prefLabel
Medial temporal lobe atrophy on MRI scans and the diagnosis of Alzheimer disease.
@en
Medial temporal lobe atrophy on MRI scans and the diagnosis of Alzheimer disease.
@nl
P2093
P2860
P1433
P1476
Medial temporal lobe atrophy on MRI scans and the diagnosis of Alzheimer disease
@en
P2093
D A Loewenstein
P2860
P304
P356
10.1212/01.WNL.0000336925.79704.9F
P407
P577
2008-12-01T00:00:00Z